[FATE] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
01-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 14.61%
YoY- -57.08%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 14,225 7,558 2,429 1,026 1,026 1,026 1,026 54.93%
PBT -43,308 -58,684 -26,609 -16,782 -10,684 -8,737 -6,886 35.82%
Tax -11,315 0 910 339 378 37 4 -
NP -43,308 -58,684 -26,609 -16,782 -10,684 -8,737 -6,886 35.82%
Tax Rate - - - - - - - -
Total Cost 57,533 66,242 29,038 17,808 11,710 9,763 7,912 39.14%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -304.45 -776.45 -1,095.47 -1,635.67 -1,041.33 -851.56 -671.15 -12.33%
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -0.45 -0.68 -0.40 -0.31 -0.26 -0.27 -0.24 11.03%
EPS Diluted -0.45 -0.68 -0.40 -0.31 -0.26 -0.27 -0.24 11.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.